VanEck Biotech ETF (BBH)
NASDAQ: BBH · Real-Time Price · USD
240.41
-0.82 (-0.34%)
At close: Aug 24, 2026, 4:00 PM EDT
240.37
-0.04 (-0.02%)
After-hours: Aug 24, 2026, 7:30 PM EDT
BBH Holdings Information
BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 16.29%, Gilead Sciences at 12.94%, Vertex Pharmaceuticals at 8.76%, Regeneron Pharmaceuticals at 7.43%, and Revolution Medicines at 5.26%.
Total Holdings
25
Top 10 Percentage
71.64%
Asset Class
Equity
ETF Category
Health
Assets
476.57M
PE Ratio
24.46
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | AMGN | Amgen Inc. | 16.29% |
| 2 | GILD | Gilead Sciences, Inc. | 12.94% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 8.76% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.43% |
| 5 | RVMD | Revolution Medicines, Inc. | 5.26% |
| 6 | NTRA | Natera, Inc. | 5.21% |
| 7 | IQV | IQVIA Holdings Inc. | 4.98% |
| 8 | ARGX | argenx SE | 4.25% |
| 9 | BIIB | Biogen Inc. | 3.27% |
| 10 | ONC | BeOne Medicines AG | 3.25% |
| 11 | ILMN | Illumina, Inc. | 3.22% |
| 12 | INSM | Insmed Incorporated | 2.93% |
| 13 | MRNA | Moderna, Inc. | 2.83% |
| 14 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.68% |
| 15 | INCY | Incyte Corporation | 2.45% |
| 16 | UTHR | United Therapeutics Corporation | 2.42% |
| 17 | BNTX | BioNTech SE | 1.78% |
| 18 | CRL | Charles River Laboratories International, Inc. | 1.72% |
| 19 | NBIX | Neurocrine Biosciences, Inc. | 1.72% |
| 20 | ICLR | ICON Public Limited Company | 1.70% |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 1.48% |
| 22 | TECH | Bio-Techne Corporation | 1.46% |
| 23 | QGEN | Qiagen N.V. | 1.09% |
| 24 | TEM | Tempus AI, Inc. | 0.85% |
| 25 | n/a | Us Dollar | 0.03% |
As of Aug 14, 2026